In principle, synergy is plausible in a few situations: Complementary pathways (e.g., appetite control + strength training adherence) Non-overlapping side-effect profiles Clear outcome tracking (so you can actually attribute effects) Where it tends to fall apart: Redundancy (two agents trying to push the same pathway) Hormonal axis pressure (especially GH/IGF-1 axis stacking) Long timelines with weak evidence (people run stacks for months because its peptides, not because outcomes justify it) For the rest of this article, Ill treat each stack as a clinical hypothesis and ask a simple question: If this were my patient, what would I be confident saying based on human evidenceand what would I label unknown? The 7 stacks people search for most (and what the evidence really supports) Quick comparison table Now, lets go stack by stack
Trommelmans, L., Selling, J
Longitudinal evaluation of demyelinated lesions in a multiple sclerosis model using ultrashort echo time magnetization transfer (UTE-MT) imaging
What is the recommended daily dose of 5-amino-1MQ (5-amino-1-methylquinoline) for a male athlete?
Periodontal and microbiological data in patients with mucous membrane pemphigoid in a French population in 2021-2022: a pilot cross-sectional study
We assess and plan at consultation
